Search

Parabolic Drugs

Sector: Healthcare | Industry: Drugs & Pharma
R 3.60 -0.05  | -1.37% -49.30% - 22.47
NSE Price: Sep 19, 15:57 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Sep 19, 15:57 3.60 -0.05 -1.37% 3.75 3.65 5,044 3.55 - 3.75
BSE Sep 19, 2018 3.63 -0.19 -4.97% 3.63 3.82 1,000 3.63 - 3.63
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 42,948 P/B: -0.03 NSE Code: PARABDRUGS
52-Week Range: R 2.90 - 12.00 Dividend Yield: 0.00% BSE Code: 533211
TTM EPS: R -8.80 Book Value: R -145.02 Face Value: R 10
Price Graph
  • Laurus Labs (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Parabolic Drugs -57.49 -2.42 -19.87 -48.95 -23.18 -4.41 -
NIFTY Smallcap 100* -20.30 -3.66 -4.22 -9.77 12.30 20.94 9.21
NIFTY Pharma* 8.79 7.96 12.30 12.05 -6.37 7.90 13.37
Company's return has been calculated on basis of BSE's price.
As on Sep 19, 2018
*As on Sep 18, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -2.52 -44.49 -39.50
Net Profit 77.75 6.03 -216.11
EPS 77.75 6.03 -216.11
Book Value -10.00 -505.53 -214.39
Average
Operating Margin -96.40 -202.72 -129.97
Net Margin -133.28 -308.58 -194.83
Return on Networth 0.00 0.00 -57.66
Return on Investment -47.01 -49.99 -35.83
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -20.83 -19.84 -41.83
Operating Profit -51.28 -391.67 57.21
Net Profit 26.28 16.57 -118.23
EPS 26.28 16.57 -118.23
TTM
Revenue -4.38 -11.80 -5.59
Operating Profit -31.49 -46.87 62.41
Net Profit 3.69 -25.18 49.65
EPS 3.69 -25.18 49.65
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Parabolic Drugs 22.47 69.43 -54.49 -77.98 0.00 -0.03 -
FDC 4,209.22 1,110.50 190.12 16.22 13.67 3.20 22.14
Laurus Labs 4,608.58 2,116.80 145.26 6.78 11.97 3.09 31.73
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Mar 14, 2016 BTS India Pvt Equity Fund Ltd  Sell Market 687,081 5.40 37.10
Jan 06, 2016 BTS India Pvt Equity Fund Ltd  Sell Market 1,391,000 10.20 141.88
Jul 04, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 26,424 8.65 2.29
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Buy Market 44,653 7.50 3.35
Jun 25, 2014 Parabolic Infrastructure Pvt. Ltd.  Sell Market 7,740 7.50 0.58
Fund Houses invested in the stock
Fund Mar-13 Dec-12 Sep-12 Jun-12 Mar-12
UTI Mutual Fund 0.481 0.899 1.900 2.457 2.301
Figures given above are % of equity capital
News & Announcements
Contact Information

Company: Parabolic Drugs Ltd.

Address: S.c.o. 186-187, 2nd Floor, Sector 8c, Chandigarh, Punjab - 160017 | Phone: +91-172-3914646/3914647/38 | Fax: +91-172-3914645

Website: www.parabolicdrugs.com

Registrar & Transfer Agent: Link Intime India Pvt Ltd.

Address: Narang Tower 44, Community Centre,Naraina Industrial Area Phase - 1,New Delhi - 110 028, Narang Tower 44, Community Centre, Naraina Industrial Area, Phase - 1

Email: Delhi@Intimespectrum.com

comments powered by Disqus
Essential checks
Altman Z-Score
-3.48
Piotroski F-Score
6
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
-0.03
Earnings Yield
EBIT / Enterprise value
-4.73%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,714.40 +2.30%
Caplin Point Laboratories R478.50 -3.22%
Dishman Carbogen Amcis R271.25 -2.11%
FDC R241.35 -0.52%
Granules India R111.65 0.00%
Laurus Labs R435.45 +0.39%
Merck R2,963.20 -4.16%
Shilpa Medicare R501.05 -1.34%
Strides Pharma Science R489.80 -1.69%
Suven Life Sciences R289.30 -4.13%
As on Sep 19, 15:59